Follow Us

The Latest

Promo Image

Once a Day Kaletra Gets Approved for Treatment Experienced, but With Caution

In April 2010, the FDA approved the once-a-day dosing of Kaletra (lopinavir + ritonavir) for adults who have taken HIV therapy before but with two or less lopinavir mutations. This new dose is not recommended for those with 3 or more of the following...

Promo Image

Kaletra™ (ABT-378/r) Application for Accelerated Approval

On June 1 Abbott Laboratories announced that it had filed a New Drug Application with the U.S. FDA for accelerated approval of its new protease inhibitor, new brand name Kaletra (pronunciation Kuh Lee Truh) (generic name lopinavir/ritonavir, most wid...